Webinar: A Leading Academic Medical Center Deploys an IT Solution for Genomics in Cancer Diagnostics [Video]

Analysis of genetic information, referred to as genomics or precision medicine, is increasingly used in healthcare to better diagnose and treat patients. Sectra has launched a new, cloud-based diagnostic IT module for genomics, within molecular pathology, in collaboration with Penn Medicine. This integrated end-to-end solution is a significant and crucial leap forward for integrated diagnostics by increasing quality and efficiency within molecular pathology while reducing turnaround times.

Join Salvatore Priore, MD, PhD of Penn Medicine, and Fredrik Lysholm, PhD of Sectra, as they discuss the process and challenges of implementing a genomics solution.

About Sectra
Sectra contributes to a healthier and safer society by assisting health systems throughout the world to enhance the efficiency of care, and authorities and defense forces in Europe to protect society’s most sensitive information. The company, founded in 1978, is headquartered in Linköping, Sweden, with direct sales in 19 countries, and distribution partners worldwide. Sales in the 2022/2023 fiscal year totaled SEK 2,351 million. The Sectra share is quoted on the Nasdaq Stockholm exchange. For more information, visit Sectra’s website.